by admin | May 8, 2026 | press-releases
Home CG Oncology Reports… PRESS RELEASE CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates Listen to this article now Following alignment discussions with FDA, BLA completion for HR BCG-unresponsive NMIBC is expected fourth...
by admin | May 5, 2026 | press-releases
Home PRESS RELEASE CG Oncology to Present at Upcoming Investor Conferences in May Listen to this article now DALLAS, May 05, 2026 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw...
by admin | Feb 27, 2026 | press-releases
Home CG Oncology Reports… PRESS RELEASE CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates Listen to this article now PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy as an adjuvant therapy in intermediate-risk...
by admin | Feb 23, 2026 | press-releases
Home PRESS RELEASE CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference Listen to this article now IRVINE, Calif., February 23, 2026 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief...
by admin | Jan 9, 2026 | press-releases
Home PRESS RELEASE CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO PLAYER =============================== -->...
by admin | Jan 6, 2026 | press-releases
Home CG Oncology to Present… PRESS RELEASE CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO PLAYER =============================== -->...